Toggle Main Menu Toggle Search

Open Access padlockePrints

Vegetarian diets and cancer risk: pooled analysis of 1.8 million women and men in nine prospective studies on three continents

Lookup NU author(s): Dr Yashvee DunneramORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2026.Background: Vegetarian diets might influence cancer risk. Methods: We studied 1,645,555 meat eaters, 57,016 poultry eaters, 42,910 pescatarians, 63,147 vegetarians and 8849 vegans in 9 cohorts (UK, US, Taiwan, India). After a median 16 years follow-up, incident cancers were: 4504 mouth and pharynx, 1308 oesophagus (squamous cell), 2105 oesophagus (adenocarcinoma), 3578 stomach, 30,528 colorectum, 2970 liver, 8030 pancreas, 3077 lung (never smokers), 61,368 breast, 11,220 endometrium, 8076 ovary, 45,946 prostate, 7193 kidney, 6869 bladder, 11,651 non-Hodgkin lymphoma, 4658 multiple myeloma and 7306 leukaemia. Multivariable Cox regression was used to estimate cohort-specific hazard ratios (HRs) and 95% confidence intervals (CIs), and the results were combined using meta-analysis. Results: Compared to meat eaters, poultry eaters had lower risk of prostate cancer (0.93, 0.88–0.98), pescatarians had lower risks of colorectal (0.85, 0.77–0.93), breast (0.93, 0.88–0.98) and kidney cancer (0.73, 0.58–0.93), vegetarians had lower risks of cancers of the pancreas (0.79, 0.65–0.97), breast (0.91, 0.86–0.97), prostate (0.88, 0.79–0.97), kidney (0.72, 0.57–0.92) and multiple myeloma (0.69, 0.51–0.93) but higher risk of squamous cell carcinoma of the oesophagus (1.93, 1.30–2.87), and vegans had higher risk of colorectal cancer (1.40, 1.12–1.75). Conclusions: Vegetarian diets might influence risk for several cancers. The generalisability should be considered cautiously.


Publication metadata

Author(s): Dunneram Y, Lee JY, Watling CZ, Lawson I, Parsaeian M, Fraser GE, Butler FM, Prabhakaran D, Shridhar K, Kondal D, Mohan V, Ali MK, Narayan KMV, Tandon N, Tong TYN, Travis RC, Chiu THT, Lin M-N, Lin C-L, Yang H-C, Liang Y-J, Greenwood DC, Reeves GK, Papier K, Floud S, Sinha R, Liao LM, Loftfield E, Cade JE, Key TJ, Perez-Cornago A

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2026

Pages: epub ahead of print

Online publication date: 27/02/2026

Acceptance date: 16/12/2025

Date deposited: 09/03/2026

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41416-025-03327-4

DOI: 10.1038/s41416-025-03327-4

Data Access Statement: The individual participant data are owned by the individual participating cohorts and are available to researchers on consent from participating cohorts. Code available through contact with the research team


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Cancer Research UK (C8221/A29017 and C8221/ A29186)
National Heart Lung and Blood Institute (HHSN2682009000026C and PO1HL154996)
Medical Research Council (MR/Y013662/1)
UKRI (MR/X032809/1)
World Cancer Research Fund (WCRF)
Wellcome (LEAP 205212/Z/16/ Z)

Share